HRP20180327T1 - Sredstva za uporabu u slučaju intolerancije na fruktozu - Google Patents

Sredstva za uporabu u slučaju intolerancije na fruktozu Download PDF

Info

Publication number
HRP20180327T1
HRP20180327T1 HRP20180327TT HRP20180327T HRP20180327T1 HR P20180327 T1 HRP20180327 T1 HR P20180327T1 HR P20180327T T HRP20180327T T HR P20180327TT HR P20180327 T HRP20180327 T HR P20180327T HR P20180327 T1 HRP20180327 T1 HR P20180327T1
Authority
HR
Croatia
Prior art keywords
fructose
use according
dehydrogenase
fructose dehydrogenase
intolerance
Prior art date
Application number
HRP20180327TT
Other languages
English (en)
Croatian (hr)
Inventor
Daniel Henry Wyrobnik
Isaac Harry Wyrobnik
Elliad Ronen Silcoff
Original Assignee
Pro Natura Gesellschaft für gesunde Ernährung mbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102006012244A external-priority patent/DE102006012244A1/de
Priority claimed from DE102006013624A external-priority patent/DE102006013624B4/de
Application filed by Pro Natura Gesellschaft für gesunde Ernährung mbH filed Critical Pro Natura Gesellschaft für gesunde Ernährung mbH
Publication of HRP20180327T1 publication Critical patent/HRP20180327T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/52—Isomerases (5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01124—Fructose 5-dehydrogenase (NADP+) (1.1.1.124)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0102—Alpha-glucosidase (3.2.1.20)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01026—Beta-fructofuranosidase (3.2.1.26), i.e. invertase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y503/00—Intramolecular oxidoreductases (5.3)
    • C12Y503/01—Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
    • C12Y503/01005—Xylose isomerase (5.3.1.5)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/904—Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HRP20180327TT 2005-11-16 2006-11-15 Sredstva za uporabu u slučaju intolerancije na fruktozu HRP20180327T1 (hr)

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
DE102005055081 2005-11-16
DE102005056169 2005-11-23
DE102005060768 2005-12-16
DE102005060769 2005-12-16
DE102006000881 2006-01-04
DE102006000873 2006-01-04
DE102006001015 2006-01-05
US75742406P 2006-01-10 2006-01-10
US75741406P 2006-01-10 2006-01-10
DE102006012244A DE102006012244A1 (de) 2005-11-16 2006-03-15 Mittel zur Anwendung bei Fructoseintoleranz
DE102006013624A DE102006013624B4 (de) 2005-11-23 2006-03-22 Mittel zur Anwendung bei Fructoseintoleranz
DE102006014423 2006-03-27
US83117406P 2006-07-17 2006-07-17
US83105006P 2006-07-17 2006-07-17
EP06820896.6A EP1951290B1 (en) 2005-11-16 2006-11-15 Agent for use in the case of fructose intolerance
PCT/IB2006/003223 WO2007057749A2 (en) 2005-11-16 2006-11-15 Agent for use in the case of fructose intolerance

Publications (1)

Publication Number Publication Date
HRP20180327T1 true HRP20180327T1 (hr) 2018-04-06

Family

ID=38049014

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20180327TT HRP20180327T1 (hr) 2005-11-16 2006-11-15 Sredstva za uporabu u slučaju intolerancije na fruktozu

Country Status (13)

Country Link
US (3) US20090081300A1 (https=)
EP (2) EP1951290B1 (https=)
JP (1) JP2009519897A (https=)
KR (1) KR20080080122A (https=)
AU (1) AU2006314188B2 (https=)
CA (1) CA2669431C (https=)
CY (1) CY1119940T1 (https=)
HR (1) HRP20180327T1 (https=)
IL (1) IL191363B (https=)
PL (1) PL1951290T3 (https=)
SI (1) SI1951290T1 (https=)
WO (1) WO2007057749A2 (https=)
ZA (1) ZA200805143B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1951289B1 (en) * 2005-11-23 2018-11-14 Pro Natura Gesellschaft für Gesunde Ernährung mbH Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity)
AU2013211517B2 (en) * 2005-11-23 2016-06-30 Pro Natura Gesellschaft Fur Gesunde Ernahrung Mbh Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity)
DE102007008664B4 (de) * 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
EP2161034A1 (de) 2008-09-04 2010-03-10 Sciotec Diagnostic Technologies GmbH Behandlung von Fruktose-Malabsorption
EP2340035B1 (de) 2008-09-04 2014-07-16 Sciotec Diagnostic Technologies GmbH Behandlung von fruktose-malabsorption
WO2010107414A1 (en) * 2009-03-19 2010-09-23 Amano Enzyme Inc. Enzyme compositions and use thereof
EP3415631A1 (en) * 2017-06-13 2018-12-19 RWTH Aachen Methods of producing 5-ketofructose
JP7469332B2 (ja) * 2019-05-13 2024-04-16 サミ－サビンサ グループ リミテッド フルクトフィリック乳酸産生細菌
CN112536005B (zh) * 2020-11-05 2022-05-03 华南理工大学 一种淀粉包埋香气物质微胶囊及其制备方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107291A (en) * 1969-06-05 1978-08-15 Sankyo Company Limited Compositions for cleaning teeth and oral cavity
US4396602A (en) * 1981-09-22 1983-08-02 Asahi Kasei Kogyo Kabushiki Kaisha Blood glucose level lowering agents
DK8502857A (https=) * 1984-06-25 1985-12-26
JPS6236191A (ja) * 1985-08-09 1987-02-17 House Food Ind Co Ltd 固定化酵素の製造方法
SE8505783D0 (sv) 1985-12-06 1985-12-06 Rolf Bergkvist Forfarande for framstellning av livsmedelsprodukter och dessas anvendning
JPH0640824B2 (ja) * 1987-03-19 1994-06-01 東洋紡績株式会社 安定なフラクト−スデヒドロゲナ−ゼ組成物
US5068110A (en) * 1987-09-29 1991-11-26 Warner-Lambert Company Stabilization of enteric coated dosage form
US6165500A (en) * 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
FI905402A7 (fi) 1990-11-01 1992-05-02 Alko Ab Oy Oligosakkaridiseos ja menetelmä sen jälkikäsittelyksi
US5650156A (en) * 1993-02-22 1997-07-22 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of nutriceuticals and compositions useful therefor
US5759539A (en) * 1995-06-06 1998-06-02 Georgia Research Foundation, Inc. Method for rapid enzymatic alcohol removal
US6057139A (en) * 1995-06-29 2000-05-02 Mcneil-Ppc, Inc. Preblend of microcrystalline cellulose and lactase for making tablets
CA2294525A1 (en) * 1997-06-17 1998-12-23 Monsanto Company Expression of fructose 1,6 bisphosphate aldolase in transgenic plants
AU740108B2 (en) 1997-06-17 2001-11-01 Novozymes A/S An oral care composition comprising a bacillus pullulanase and a dextranase
AU762967B2 (en) * 1998-05-13 2003-07-10 Novozymes A/S Methods for using dehydrogenases in baking
CA2328137A1 (en) * 1998-05-29 1999-12-09 Novo Nordisk A/S Methods for using xyloglucan endotransglycosylase in baking
US6042823A (en) 1998-07-02 2000-03-28 Amano Pharmaceuticals Co., Ltd. Enzyme composition and use thereof
US7767203B2 (en) * 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
JP2000125883A (ja) * 1998-10-21 2000-05-09 Internatl Reagents Corp フルクトキナーゼ及びその遺伝子
AU6326699A (en) 1998-11-05 2000-05-29 Novozymes A/S Methods for using a glucose isomerase in baking
IL138990A0 (en) * 1999-02-12 2001-11-25 Biostream Inc Matrices for drug delivery and methods for making and using the same
EP1203822A1 (en) * 2000-11-02 2002-05-08 Societe Des Produits Nestle S.A. Extracellular polysaccharide from Gluconacetobacter spp
US6754884B1 (en) 2001-07-02 2004-06-22 Bea Systems, Inc. Programming language extensions for processing XML objects and related applications
JP4824886B2 (ja) * 2001-09-11 2011-11-30 長岡香料株式会社 フルクトース吸収阻害剤、組成物、および食品
US20030113310A1 (en) * 2001-12-17 2003-06-19 Van Laere Katrien Maria Jozefa Method for the treatment of obesity, overweight and fluctuations in blood insuline and/or glucose levels
ES2533469T3 (es) * 2002-10-11 2015-04-10 Novozymes A/S Método de preparación de un producto tratado con calor
JP2004261174A (ja) * 2003-02-13 2004-09-24 Fujicco Co Ltd 豆乳発酵物およびそれを用いた飲食品
WO2004079848A2 (en) 2003-03-03 2004-09-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Novel electrode with switchable and tunable power output and fuel cell using such electrode
JPWO2006004106A1 (ja) * 2004-07-05 2008-04-24 マルキンバイオ株式会社 ザクロ果汁、ザクロ果汁粉末及び該粉末の製造方法
EP1951289B1 (en) * 2005-11-23 2018-11-14 Pro Natura Gesellschaft für Gesunde Ernährung mbH Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity)

Also Published As

Publication number Publication date
WO2007057749A3 (en) 2008-10-16
US20090081300A1 (en) 2009-03-26
ZA200805143B (en) 2012-02-29
AU2006314188A1 (en) 2007-05-24
KR20080080122A (ko) 2008-09-02
SI1951290T1 (en) 2018-04-30
IL191363B (en) 2018-05-31
EP3318271A1 (en) 2018-05-09
US20180344818A1 (en) 2018-12-06
CA2669431C (en) 2019-04-23
EP1951290B1 (en) 2017-12-27
CY1119940T1 (el) 2018-12-12
JP2009519897A (ja) 2009-05-21
PL1951290T3 (pl) 2018-05-30
WO2007057749A2 (en) 2007-05-24
CA2669431A1 (en) 2007-05-24
US10568942B2 (en) 2020-02-25
EP1951290A2 (en) 2008-08-06
US9446101B2 (en) 2016-09-20
AU2006314188B2 (en) 2014-01-16
US20130224171A1 (en) 2013-08-29
EP1951290A4 (en) 2009-03-11

Similar Documents

Publication Publication Date Title
WO2006123248A3 (en) Improved methods and devices for delivering a therapeutic product to the ocular sphere of a subject
US20110171283A1 (en) Composition containing at least one nutrivite, at least one disinfecting or decontaminating, and/or at least one protease-inhibiting active compound and/or active compound complex
WO2009002867A3 (en) Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
NO2014028I2 (no) Glukopyranosyl-substituerte benzenderivater, fremgangsmåte for fremstilling av disse, fysiologisk akseptable salter av slike forbindelser, medikamenter inneholdende slike forbindelser og kombinasjoner med andre aktive substanser samt deresanvendelse for fremstilling av medikamenter for behandling av sykdom
BRPI0520082A2 (pt) formas de dosagem de risedronato
MX344476B (es) Metodos de tratar trastornos pulmonares con formulaciones de amikacina liposomal.
AR058679A1 (es) Preparacion farmaceutica que contiene meloxicam
UY29377A1 (es) Nuevas formilaciones líquidas de rotavirus, su preparación y sus usos.
WO2008085484A3 (en) Treatment of inflammatory bowel disease with enteric coated formulations comprising 5-aminosalicylic acid or 4-aminosalicylic acid
MX2010013766A (es) Rasagilina para modificacion de enfermedad de parkinson.
EP1968601A4 (en) SALTS OF KALIUM ATP CHANNEL OPENERS AND ITS USES
MX2007004882A (es) Derivados de xantina con actividad de receptor de hm74a.
WO2008027854A3 (en) Pharmaceutical compositions comprising hgh for oral delivery
WO2008149802A1 (ja) アンドログラホリドを有効成分とする抗疲労剤及び経口組成物
ITMI20031617A1 (it) Microcapsule a doppio strato di polisaccaridi utilizzabili
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
HRP20180327T1 (hr) Sredstva za uporabu u slučaju intolerancije na fruktozu
NO20080244L (no) Doseringsstyring for prasugrel
MX341660B (es) Agonista del receptor de ghrelina para el tratamiento de caquexia.
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
AR048318A1 (es) Formulaciones de matriz orales que comprenden licarbazepina
WO2005087255A3 (en) Method of optimizing treatment with interferon-tau
BRPI0507733A (pt) composição para a liberação de um agente hipnótico através da mucosa oral, e, método para tratar um distúrbio do sono em um paciente em necessidade deste
TWM478502U (zh) 一種使老舊細胞透過鈉鉀離子通道排出而達到細胞活化功效之蕉科植物與仙人掌萃取物包埋結構